George Institute Co-Founder Nominated Among Australia’s Top Influential Women

George Institute Co-Founder Nominated Among Australia’s Top Influential Women

The George Institute for Global Health’s Co-Founder and Principal Director Dr. Robyn Norton has been nominated as one of The Australian Financial Review’s 2019 top 100 Women of Influence, recognizing her leadership and trailblazing efforts in global health and gender equity. The Women of Influence Award celebrate women leaders who have pushed back against unfairness, […]

Read More

October 18th, 2019

Sean Hart Named Chief Business Officer of George Clinical

SYDNEY, October 8, 2019 – George Clinical, a global scientifically-driven clinical research organization (CRO), today announced the promotion of Sean Hart to the new role of Chief Business Officer. Hart, who joined George Clinical through the acquisition of Vector Oncology in 2017, will now lead business development functions globally for the organization. “Sean has demonstrated […]

Read More

October 8th, 2019

George Clinical Grows European Presence with New Location in the United Kingdom

LONDON, August 19, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom.  The office is based in London and compliments the organization’s growing list of global locations throughout the Asia-Pacific region, the United […]

Read More

September 17th, 2019

The George Institute and UNSW Founders Build Ecosystem for Health Innovations

In what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, University of New South Wales—Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program dubbed Health10x designed to accelerate and scale up health focused start-ups. The Health10x program was conceived […]

Read More

September 11th, 2019

Professor Bruce Neal Appointed Executive Director of The George Institute

George Clinical is pleased to announce that Dr. Bruce Neal has been appointed Executive Director of The George Institute Australia effective September 1.   Neal was a founding member of the Institute, together with John Chalmers and Principal Directors Stephen MacMahon and Robyn Norton.  Neal has contributed to the growth of the Institute across many areas […]

Read More

September 5th, 2019

WHO Endorsement of Simpler Drug Treatment for Blood Pressure Will Improve Treatment Availability for 1 Billion People

George Clinical welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization (WHO) Essential Medicines List (EML) in response to an application filed by Resolve to Save Lives (RTSL), an initiative of vital strategies, The George Institute and other partners. Adding FDCs of blood pressure lowering […]

Read More

July 31st, 2019

The George Institute Researchers Find Diabetes Increases the Risk of Heart Failure for Women at a Higher Rate

A global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men.  Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]

Read More

July 19th, 2019

Big and Small Pharma Enjoy a Significant Opportunity to Leverage India for Trials

The Indian subcontinent deserves to be considered by pharmaceutical or biotech firms examining clinical trial locations, and veteran industry players may be surprised to learn India is already a leading destination for global clinical trials with significant growth taking place in the biotech sector.   Prime opportunities exist for all phases of clinical trials due to […]

Read More

July 17th, 2019

Award Highlights George Clinical as Leading Employer in Asia-Pacific Region

Last year George Clinical gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong.  The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong where Evon Hui, Head of Business Operations, East Asia, accepted the […]

Read More

July 13th, 2019

George Clinical Announces the Appointment of Meelian Hoh as Chief Financial Officer

SYDNEY, June 17, 2019 – George Clinical, a global scientifically driven CRO, today announced the appointment of Meelian Hoh to the role of Chief Financial Officer. With extensive financial management experience spanning more than 20 years, Hoh brings leadership in financial accountability, enterprise system implementation and pharma industry market knowledge to the George Clinical executive […]

Read More

June 18th, 2019

Join our Mailing List


Add George Clinical to your network